home · search · CK Directory · maps · calendar · sitemap · help
Community Services
Business Resources
Recreation & Tourism
Council & Administration
Living in Chatham-Kent
Public Health
Emergency Services
Public Safety
Education
Library
Jobs
Getting Involved
Special Event Planning
Transportation
Licenses & Permits
Welcome Newcomers
Economic Development
Services For Business
Building & Development
Agri-Business
RFP's, Bids & Tenders
CK Small Business Centre
Tourism
Arts & Entertainment
Shopping & Dining
Heritage & Museums
Recreation & Parks
Sports
Rental Facilities
RecConnect
Mayor, Council and CAO
Municipal Departments
By-Laws
Government Resources
Restructuring History
Media Releases
Public Health
Immunization

Childrens Immunization
Parent Information & Immunization Schedule
Student Immunization Record
The Yellow Card
New Vaccines
School Programs
Clinics at School
Keeping Your Child Healthy
Hepatitis B Vaccine
Measles, Mumps and Rubella (MMR) Vaccine
Pentacel Vaccine
Quadracel Vaccine
Menjugate Vaccine
Prevnar Vaccine
Varivax III Vaccine
Kids Under Two Need A Flu Shot Too
Influenza (Flu) Vaccine
Online Reporting of Immunizations
2010 Immunization Clinic Schedule
H1N1
Keeping You Healthy
Environmental Health
Family Health
Communicable Diseases
Physical Activity
Best Start
Cancer
Healthy Living Program
Workplace Wellness
Immunization
Pregnancy & Infant Care
Parenting 0-6 years
Pandemic Information
Smoking, Alcohol and Substance Addictions
For Health Care Professionals
For Teachers
Recent News
Sammy and Snooper's Home Safety Game
Patient Appointment Request Service
Travel Clinic
Convictions
Contact Us
Menjugate Vaccine
Vaccines (needles or baby shots) are the best way to protect people against some very serious infections. The National Advisory Committee on Immunization (NACI) and the Canadian Paediatric Society recommend meningococcal immunization using Menjugate in infants, children, adolescents and young adults. The vaccine provides prolonged immunity against type C meningococcal bacteria.

What are meningococcal Infections?

Meningococcal diseases are caused by the bacterium, Neisseria meningitidis. It can cause serious infection of the covering of the brain (meningitis) or blood infection (septicemia). Approximately 11% of persons who become ill with a serious meningococcal infection will die.


Is meningococcal bacteria contagious?

Yes, it is contagious. It can spread from person to person by coughing and sneezing, kissing, sharing food or drink, or with young children when sharing toys that are frequently put into the mouth, such as those used for teething. The bacteria can be found in the nose and throat of many healthy infants, children and adults without causing illness.

The highest number of cases of meningococcal disease occurs in children under 1 year of age followed by children between 1 to 4 years. Outbreaks have occurred in Canada, especially in the schools, with most due to the group C type meningococcal bacteria.

Can antibiotics be used to treat meningococcal infections?

There are antibiotics that can treat meningococcal infections. However, even when the best antibiotics are given under the best circumstances, meningococcal infection can kill or permanently injure adults and children.


Is there a vaccine to protect infants, children, adolescents and adults?


Menjugate is a vaccine that helps to protect from serious meningococcal group C disease. NACI has recommended that it be given to infants, children 1 to 4 years of age, adolescents and young adults. It should also be administered to household contacts of cases of meningococcal group C disease. The vaccine has been shown to provide protection in 90% of persons vaccinated.


What is the immunization schedule?


The vaccine schedule for infants is 2, 4 and 6 months (3 doses given with a minimum of a 4 week interval between doses). Infants 4 to 11 months of age who have not previously received the vaccine should receive 2 doses at least 4 weeks apart. Individuals one year of age and older require a single dose of the vaccine.

Are there any side effects?

Mild reactions to the vaccine have been reported including pain and redness at the injection site. More severe side effects including fever, difficulty breathing and hives have occurred but rarely.

Temporary headache, relieved by over-the-counter painkillers, is another side effect that is sometimes seen after the Menjugate vaccine.

Who should get the vaccine?

It is safe and should be considered for all infants, children 1 to 4 years of age, adolescents and young adults. It should also be used to immunize household and intimate contacts of severe meningococcal group C disease.

Who should not get the vaccine?

Menjugate should not be given to anyone if they have a known allergy to any of the components of the vaccine.

In the case of illness, consult with your health care provider about deferring the immunization until after the illness has ended.

When you bring your infant, child or yourself in for vaccination….

  1. Get the facts. A doctor or health care professional can answer any concerns or questions you may have.
  2. Tell the health care professional about any allergies, medications, illnesses or any previous suspected reaction to any vaccine, since they may affect a person's response to vaccination.
  3. Keep a written vaccination record in case you change doctors, move or forget which vaccines were given and when they were administered. Records of vaccines are required for attendance at daycare and school.

Source: Halton Region Health Department



For more information contact Public Health at 519-355-1071 ext. 5900 or online at CKhealth@chatham-kent.ca

Posting created by: Health and Family Services group.
Last updated: Wednesday, April 23, 2008
CK Directory
Access Chatham-Kent business and service information.

Search CK Directory

Home·Community Services·Business Resources·Recreation & Tourism·Council & Administration
© Copyright 2004 Municipality of Chatham-Kent · Terms of Use · Privacy Policy · Contact Us